Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.

Source:http://linkedlifedata.com/resource/pubmed/id/15942461

Download in:

View as

General Info

PMID
15942461